OCULAR THERAPEUTIX, INC financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
OCUL on Nasdaq
Location
Bedford, MA
Fiscal year end
31 December
Latest financial report
05 Feb 2026

Latest SEC snapshot (2026-02-02) highlights Return On Equity -54.9%, Return On Assets -26.7%, and Operating Margin -526.5%.

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

15.4/100

Weak Confidence high

Return On Equity

-55%

Metric score 0.0/100

Return On Assets

-27%

Metric score 0.0/100

Financial Health

Current Ratio
15.39x
Quick Ratio
15.11x
Debt to Equity
0.12x

Strengths

Debt-to-equity

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Return On Equity

-55%

YoY: -42%

Industry median: -43% (n=671)

View history

Return On Assets

-27%

YoY: -23%

Industry median: -48% (n=669)

View history

Operating Margin

-526%

YoY: +93%

Industry median: -128% (n=298)

View history

Current Ratio

15.39x

YoY: +44%

Industry median: 3.39x (n=667)

View history

Quick Ratio

15.11x

YoY: +47%

Industry median: 2.02x (n=287)

View history

Debt-to-equity

0.12x

YoY: +5.1%

Industry median: 0.28x (n=634)

View history

Revenues YoY

-18%

YoY:

Industry median: 5% (n=103)

View history

NetIncomeLoss YoY

-37%

YoY:

Industry median: -0.54% (n=641)

View history

Profitability

Metric Latest value YoY change
Return On Equity -55% -42%
Return On Assets -27% -23%
Operating Margin -526% +93%

Financial Health

Metric Latest value YoY change
Current Ratio 15.39x +44%
Quick Ratio 15.11x +47%
Debt-to-equity 0.12x +5.1%

Growth

Metric Latest value YoY change
Revenues YoY -18%
NetIncomeLoss YoY -37%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 217,691,779
Common Stock, Shares, Outstanding 215,927,600 +37%
Common Stock, Value, Issued $22,000 +38%
Weighted Average Number of Shares Outstanding, Basic 187,241,483 +18%
Weighted Average Number of Shares Outstanding, Diluted 187,241,483 +18%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $51,951,000 -18%
Research and Development Expense $197,096,000 +54%
Selling and Marketing Expense $53,922,000 +30%
General and Administrative Expense $64,376,000 +6.1%
Costs and Expenses $321,968,000 +37%
Operating Income (Loss) $270,017,000 -57%
Nonoperating Income (Expense) $4,078,000 +133%
Earnings Per Share, Basic -1.42 -16%
Earnings Per Share, Diluted -1.42 -16%
Cash and Cash Equivalents, at Carrying Value $737,060,000 +88%
Accounts Receivable, after Allowance for Credit Loss, Current $30,650,000 -5.4%
Inventory, Net $3,564,000 +17%
Assets, Current $782,129,000 +77%
Property, Plant and Equipment, Net $19,676,000 +110%
Operating Lease, Right-of-Use Asset $4,638,000 -22%
Assets $808,057,000 +76%
Accounts Payable, Current $4,154,000 -0.53%
Employee-related Liabilities, Current $17,971,000 +26%
Accrued Liabilities, Current $43,835,000 +25%
Liabilities, Current $50,806,000 +23%
Contract with Customer, Liability, Noncurrent $14,000,000 0%
Operating Lease, Liability, Noncurrent $2,815,000 -47%
Other Liabilities, Noncurrent $887,000 +529%
Liabilities $153,747,000 +7.8%
Retained Earnings (Accumulated Deficit) $1,157,023,000 -30%
Stockholders' Equity Attributable to Parent $654,310,000 +107%
Liabilities and Equity $808,057,000 +76%
Common Stock, Shares Authorized 400,000,000 0%
Common Stock, Shares, Issued 215,927,600 +37%
Common Stock, Par or Stated Value Per Share 0.0001 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $738,674,000 +88%
Deferred Tax Assets, Valuation Allowance $292,449,000 +30%
Deferred Tax Assets, Gross $295,534,000 +29%
Operating Lease, Liability $5,632,000 -23%
Lessee, Operating Lease, Liability, to be Paid $6,336,000 -27%
Property, Plant and Equipment, Gross $47,196,000 +43%
Operating Lease, Liability, Current $2,817,000 +46%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,317,000 -25%
Lessee, Operating Lease, Liability, to be Paid, Year One $3,269,000 +20%
Operating Lease, Weighted Average Discount Rate, Percent 0.1215 +2.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $704,000 -52%
Lessee, Operating Lease, Liability, to be Paid, Year Three $750,000 -66%
Deferred Tax Assets, Operating Loss Carryforwards $189,192,000 +41%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 5,000,000 0%
Unrecognized Tax Benefits $0
Preferred Stock, Shares Outstanding 0
Deferred Tax Assets, Net of Valuation Allowance $3,085,000 -15%
Share-based Payment Arrangement, Expense $43,184,000 +30%
Preferred Stock, Par or Stated Value Per Share 0.0001 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%